AzTrials
AzTrials

Suicidal IdeationNCT07043231

Evaluation of Creative Materials Supporting Healthcare Professionals in Discussing Suicidality in Children and Adolescents

A study testing Creative materials in people with Suicidal Ideation, run by University Ghent at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Preliminary research clearly indicates a significant shortage of evidence-based tools and interventions specifically targeting suicidality among children and adolescents. The need for such methodologies is substantial, as suicidal ideation and suicide attempts are relatively common within this age group. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Suicidal Ideation
What is being tested?
Creative materials
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteBelgium
Study dates
2 Jun 2025to Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participants must be healthcare professionals (e.g., general practitioners, psychiatrists, psychologists, psychotherapists, or nurses) working in mental health care.
  • Participants must work with children or adolescents who may be experiencing suicidality.
  • Participants must be 18 years of age or older.
  • Participants must have internet access and sufficient proficiency in Dutch.

Who cannot join

  • Individuals who do not meet the inclusion criteria.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Eva De Jaegere, PhD contact

+3293320775

eva.dejaegere@ugent.be

Belgium1 site, 1 recruiting
  • Flemish Centre of Expertise in Suicide Prevention, Ghent University

    Ghent, 9000

    Eva De Jaegere, PhD, +3293320775, eva.dejaegere@ugent.be

    Recruiting

Other trials in Belgium

About this study

Preliminary research clearly indicates a significant shortage of evidence-based tools and interventions specifically targeting suicidality among children and adolescents. The need for such methodologies is substantial, as suicidal ideation and suicide attempts are relatively common within this age group. According to the 2022 Health Behaviour in School-aged Children (HBSC) study, 16% of boys and 28% of girls aged 13 to 18 reported having had suicidal thoughts on two or more occasions in their lifetime (Schrijvers et al., 2023). Compared to the previous HBSC study conducted in 2018, this represents a negative trend, as 13% of boys and 22% of girls reported suicidal thoughts at that time (Dierckens et al., 2019).

Facilitating open discussions about suicidal thoughts is therefore of critical importance. Research has shown that discussing suicidality does not increase suicidal behavior; rather, it can contribute to a reduction in risk (Blades et al., 2018; Dazzi et al., 2014; DeCou \& Schumann, 2018; Polihronis et al., 2022). Breaking the taboo around suicidality and attuning to the emotional experiences of children and adolescents may serve as an initial step toward providing effective support. Such openness can help reduce feelings of loneliness and isolation by fostering a safe environment in which young people feel heard and understood. Moreover, the act of speaking openly about suicidality is associated with increased social support-an important protective factor (Batty et al., 2018; Calati et al., 2019).

Read more

In 2023, a project was launched aimed at developing creative materials to support professionals in initiating conversations about suicidality with children and adolescents. This material is being developed through a co-creative process (EC code: ONZ-2024-0211), in collaboration with youth care professionals, method developers, and young individuals with lived experience of suicidal thoughts. These young people provide essential contributions to ensure that the materials are aligned with their needs and expectations for support. This co-creative approach aims not only to produce a theoretically grounded methodology, but also to yield a practically applicable tool that effectively addresses the real-world challenges faced by both professionals and youth. The creative materials are currently under development and are designed to facilitate exploration and discussion of suicidality, ultimately supporting professionals in formulating a risk assessment and developing a Safety Plan. This approach aligns with the recommendations outlined in the guideline "Detection and Interventions for Suicidal Thoughts and Behaviors in Children and Adolescents" (Dumon et al., 2023).

The next phase of the project focuses on evaluating the creative materials. The evaluation aims to gain insight into their usability and applicability in professional practice. This will be conducted through an evaluation study. Professionals working in Flanders will be recruited via calls on www.zelfmoord1813.be, relevant partner organizations, social media, and newsletters from VLESP and other partners. Additionally, professionals may be invited via email. Those who have used the materials over a three-month period will be asked to retrospectively share their experiences. The study consists of the following steps:

Registration: Eligible professionals complete a short registration form (duration: approximately 5 minutes).

Use of the creative materials: Participants use the materials in their professional context over a period of three months.

Post-assessment: At the end of the three-month period, participants complete a questionnaire regarding their experiences with the materials (duration: approximately 10-15 minutes).

The post-assessment focuses on evaluating user-friendliness, practical applicability, and the potential of the creative materials to facilitate conversations about suicidality. Collected feedback will be used to further refine and optimize the materials. If participants do not complete the post-assessment promptly, they will receive reminder emails after 2 and 4 days. The target sample size for the study is 40 participants.

Being tested
Creative materials
Medical subject headings
Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Creative materialsOther

    This intervention provides professionals with co-created creative materials specifically designed to facilitate structured, safe conversations about suicidality with children and adolescents. Unlike standard tools, it offers three flexible pathways-Conversation, Drawing, and Walking-allowing a personalized approach tailored to the young person's preferences and context. The materials guide professionals through the assessment of suicidal intent, risk and protective factors, and help formulate a risk assessment and Safety Plan. The content is aligned with national clinical guidelines but uniquely integrates experiential insights from youth with lived experience, ensuring both theoretical grounding and practical applicability.

Study groups in NCT07043231
Study groupRoleWhat they receive
Study groupExperimentalNot described
Receives: Other: Creative materials

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Usability of Creative Materials for Discussing Suicidality

    This is self-developed questionnaire regarding the usability of the creative materials.

    Measured: Three months after enrollment

Secondary outcomes (6)
  1. Efficacy of Creative Materials for Discussing Suicidality

    This is a self-developed questionnaire regarding the efficacy of the creative materials.

    Measured: Three months after enrollment

  2. Applicability of the creative materials for Discussing Suicidality

    This is a self-developed questionnaire regarding the applicability of the creative materials.

    Measured: Three months after enrollment

  3. Acceptability of Intervention Measure (AIM)

    This is a psychometrically validated tool developed by Weiner et al. (2017) which assesses the perceived acceptability of an intervention by stakeholders. The measure consists of 4 items, rated on a Likert scale (typically 1 = completely disagree to 5 = completely agree).

    Measured: Three months after enrollment

  4. Intervention Appropriateness Measure (IAM)

    This is a psychometrically validated tool developed by Weiner et al. (2017) which evaluates the perceived relevance or suitability of the intervention for a given setting or problem. The measure consists of 4 items, rated on a Likert scale (typically 1 = completely disagree to 5 = completely agree).

    Measured: Three months after enrollment

  5. Feasibility of Intervention Measure (FIM)

    This is a psychometrically validated tool developed by Weiner et al. (2017) which measures the extent to which an intervention can be successfully used or carried out within a setting. The measure consists of 4 items, rated on a Likert scale (typically 1 = completely disagree to 5 = completely agree).

    Measured: Three months after enrollment

  6. Implementation of the creative materials for Discussing Suicidality

    This is a self-developed questionnaire regarding the implementation of the creative materials.

    Measured: Three months after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2025
  2. Study start2 Jun 2025
  3. Primary completionNov 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07043231
Sponsor's protocol ID
ONZ-2024-0593
Status last verified
Jun 2025
First submitted
27 May 2025
Last updated
29 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Creative materials in people with Suicidal Ideation, run by University Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eva De Jaegere, PhD (+3293320775, eva.dejaegere@ugent.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Usability of Creative Materials for Discussing Suicidality (time frame: Three months after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in